News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Exelixis, Inc. (EXEL) Announces Second Quarter 2013 Financial Results



8/7/2013 7:22:50 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the quarter ended June 30, 2013.

Q2 2013 Highlights and Recent Events

•Reported net product revenue for COMETRIQ® (cabozantinib) of $4.0 million in the second quarter of 2013.

•Expanded the sales force to 14 representatives.

Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES